Cannabis Researchers Published 4,300 Scientific Papers in 2022

normal According to the recently announced PubMed.gov Keyword searchIn 2022, there were more than 4,300 scientific research papers published on cannabis. An estimated 4,200 papers will be published in 2021. Over 30,000 research papers have been published in the last 12 years. In total, there are approximately 42,500 scientific papers investigating cannabis.

It’s common to hear cannabis opponents say more research is needed before legalization takes place. normal Deputy Director Paul Armentano issued a statement refuting the allegations. “While some have argued that marijuana has not yet received sufficient scientific scrutiny, the interest of scientists in cannabis research has increased exponentially in recent years, leading to the discovery of the plant, its active ingredients, and their mechanisms of action. , and our understanding of their effects, both on users and on society,” said Armentano. “Politicians and others have ceased to evaluate cannabis through the lens of ‘what we don’t know’ and have instead turned to the evidence about marijuana and marijuana reform policy that shows us everything we know.” It’s time to start working on an argument based on it.”

NORML explored findings from research on a range of medical conditions, including chronic pain, Huntington’s disease, insomnia, multiple sclerosis, and post-traumatic stress disorder, and identified numerous cannabis-related studies from 2000 to 2021. Summary of scientific research. This review analyzes the evolution of the researcher’s cannabis range. “As clinical research into the therapeutic value of cannabinoids proliferates, researchers are gaining a better understanding of cannabis’ amazing disease-fighting capabilities.” Written by NORML“Researchers in the 1970s, 80s, and 90s primarily evaluated marijuana’s ability to temporarily relieve symptoms of various ailments, such as the nausea associated with cancer chemotherapy, but today’s scientists are exploring the potential role of cannabinoids in regulating disease.”

Even recently, the scientific community has published a number of interesting cannabis studies in recent months.One of the recent studies published in Journal of Sleep Research Finding cannabis to be an effective treatment for insomnia, researchers found that participants experienced an 80% improvement in sleep quality and 60% had clinical insomnia after completing the two-week study. Another study found evidence that cannabis had “unique beneficial effects” in patients with bipolar disorder, while one study found an association between cannabis consumption and HIV-positive patients. found to be associated with physical activity. There are also many more studies underway, including King’s College London, where he recently launched a large study of 6,000 people in September, with the goal of publishing early results in 2023 or 2024. is.

Cannabis is more mainstream than ever before. President Joe Biden recently announced a monumental move to the Medical Marijuana and Cannabidiol Research Expansion Act, which “establishes a new registration process for conducting marijuana research and manufacturing marijuana products for research purposes and for drug development.” signed. Biden also signed an infrastructure bill that includes provisions for cannabis in 2021. Attorney General and Secretary of Health and Human Services establish a “national clearinghouse” to help researchers better distribute cannabis products for research, allowing researchers to receive more samples of various strains It says it has two years to submit a report explaining how. An increasing amount of samples are for researchers who do not live in states where medical or adult-use cannabis is legal.

Meanwhile, research investigating the benefits of other psychedelic substances is also on the rise. One study in the journal psychopharmacology Found evidence that psilocybin can treat autism spectrum disorders. The University College of London also published the results of a recent study that analyzed brain imaging of consumers who attended psychedelic retreats. Another researcher at the University of Melbourne investigated how the benefits of ayahuasca outweigh the risks.